# Minimally Invasive Biopsy Predicting Breast pCR After NAC for Breast Cancer

> **NCT03789851** · NA · UNKNOWN · sponsor: **Shandong Cancer Hospital and Institute** · enrollment: 50 (estimated)

## Conditions studied

- Breast Cancer

## Interventions

- **DEVICE:** core needle biopsy

## Key facts

- **NCT ID:** NCT03789851
- **Lead sponsor:** Shandong Cancer Hospital and Institute
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-06-01
- **Primary completion:** 2019-06-15
- **Final completion:** 2020-06-01
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2018-12-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03789851

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03789851, "Minimally Invasive Biopsy Predicting Breast pCR After NAC for Breast Cancer". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03789851. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*